SOLENO THERAPEUTICS INC |
10%+ Owner |
Common Stock |
18M |
$658M |
$36.49 |
Mar 29, 2022 |
Indirect |
Jasper Therapeutics, Inc. |
10%+ Owner |
Common Stock |
5.63M |
$119M |
$21.23 |
Sep 24, 2021 |
By Abingworth Bioventures VII, LP |
Sierra Oncology, Inc. |
10%+ Owner |
Common Stock, $0.001 par value |
1.31M |
$72.3M |
$55.00 |
Jan 31, 2022 |
Indirect |
Vera Therapeutics, Inc. |
10%+ Owner |
Class A Common Stock |
2.96M |
$53.3M |
$18.00 |
May 18, 2021 |
Indirect |
eFFECTOR Therapeutics, Inc. |
10%+ Owner |
Common Stock |
4.82M |
$2.92M |
$0.61 |
Aug 25, 2021 |
Indirect |
SOLENO THERAPEUTICS INC |
10%+ Owner |
Warrant (right to buy) |
7.72M |
|
|
Mar 29, 2022 |
Indirect |
Jasper Therapeutics, Inc. |
10%+ Owner |
Stock Option (right to buy) |
78K |
|
|
Mar 21, 2022 |
Indirect |
eFFECTOR Therapeutics, Inc. |
10%+ Owner |
Stock Option (right to buy) |
40K |
|
|
Oct 6, 2021 |
Indirect |
SOLENO THERAPEUTICS INC |
10%+ Owner |
Stock Option (right to buy) |
31.9K |
|
|
Jun 1, 2021 |
Indirect |
Vera Therapeutics, Inc. |
10%+ Owner |
Stock Option (right to buy) |
9.93K |
|
|
May 13, 2021 |
Indirect |
Sierra Oncology, Inc. |
10%+ Owner |
Series B Warrants (right to buy) |
0 |
|
|
Jan 28, 2022 |
Indirect |